Please use this identifier to cite or link to this item: https://www.um.edu.mt/library/oar/handle/123456789/49150
Title: Pharmacotherapy in the treatment of clostridium difficile : impact on clinical practice
Authors: Holgado Sánchez, Noelia
Vella, Janis
Barbara, Christopher
Azzopardi, Lilian M.
Keywords: Clostridium difficile -- Chemotherapy
Clostridium difficile -- Risk factors
Microbial sensitivity tests
Issue Date: 2017-09
Publisher: University of Malta. Department of Pharmacy
Citation: Holgado Sánchez, N.,Vella, J., Barbara, C., & Azzopardi, L. M. (2017, September). Pharmacotherapy in the treatment of clostridium difficile: impact on clinical practice. Poster session presented at the 77th FIP Annual Conference, Seoul, Republic of Korea.
Abstract: A poster presentation regarding pharmacotherapy in the treatment of clostridium difficile and the impact on clinical practice. Introduction: Clostridium difficile is a pathogen accounting for 20-30% of cases of antibiotic-associated diarrhoea and is the most common cause of hospital-acquired diarrhoea. Transmission takes place by faecal-oral route. Colonization can be symptomatic or asymptomatic. Risk factors for C. difficile infection (CDI) include: recent or concomitant antibiotic exposure, older age, length of hospital stay, gastric acid suppression and immunosuppression. Aims: • To propose a framework for C. difficile culturing and antibiotic sensitivity testing with standardization of this testing procedure. • To identify risk factors for CDI and carriage of this infection.
URI: https://www.um.edu.mt/library/oar/handle/123456789/49150
Appears in Collections:Scholarly Works - FacM&SPha

Files in This Item:
File Description SizeFormat 
Pharmacotherapy_in_the_treatment_of_clostridium_difficile_impact_on_clinical_practice_2017.pdf560.54 kBAdobe PDFView/Open


Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.